Fennec Pharmaceuticals (FENC) Shareholder's Equity Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.06% |
| Sep 30, 2025 | -16.48% |
| Jun 30, 2025 | -17.15% |
| Mar 31, 2025 | -21.93% |
| Dec 31, 2024 | -20.06% |
| Sep 30, 2024 | -18.58% |
| Jun 30, 2024 | -15.80% |
| Mar 31, 2024 | -30.95% |
| Dec 31, 2023 | -20.54% |
| Sep 30, 2023 | -19.73% |
| Jun 30, 2023 | -19.05% |
| Mar 31, 2023 | -17.98% |
| Dec 31, 2022 | -15.95% |
| Sep 30, 2022 | -20.56% |
| Jun 30, 2022 | -2.47% |
| Mar 31, 2022 | 34.35% |
| Dec 31, 2021 | 34.60% |
| Sep 30, 2021 | 35.13% |
| Jun 30, 2021 | 36.79% |
| Mar 31, 2021 | 152.48% |
| Dec 31, 2020 | 121.28% |
| Sep 30, 2020 | 98.22% |
| Jun 30, 2020 | 100.61% |
| Mar 31, 2020 | 59.25% |
| Dec 31, 2019 | 80.90% |
| Sep 30, 2019 | 46.06% |
| Jun 30, 2019 | 40.82% |
| Mar 31, 2019 | 45.10% |
| Dec 31, 2018 | 75.50% |
| Sep 30, 2018 | 49.78% |
| Jun 30, 2018 | 65.01% |
| Mar 31, 2018 | 37.03% |
| Dec 31, 2017 | 49.22% |
| Sep 30, 2017 | 47.15% |
| Jun 30, 2017 | 36.47% |
| Mar 31, 2017 | 1.97% |
| Dec 31, 2016 | 99.69% |
| Sep 30, 2016 | 25.79% |
| Jun 30, 2016 | 54.50% |
| Mar 31, 2016 | 23.38% |
| Dec 31, 2015 | 16.12% |